Uniting Minds at Leading Oncology Conferences
The American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) have long been at the forefront of oncology research. These annual gatherings are not just events; they are vibrant platforms for the exchange of groundbreaking research and innovative ideas. Representing thousands of oncology professionals worldwide, ASCO and ESMO set the stage for advancements that shape the future of medical oncology.
Expanding Horizons in Dermatology, Endocrinology, Ophthalmology and Rheumatology
Beyond oncology, our focus extends to the latest developments in dermatology, endocrinology, ophthalmology, and rheumatology. Each conference brings together experts who share their insights and discoveries, driving progress in these critical fields. From cutting-edge treatments to novel research findings, these events are a testament to the relentless pursuit of excellence in healthcare.
Accessible Knowledge for All
Karger is committed to making knowledge from these conferences accessible to everyone. Our collection includes summary sheets, engaging videos and podcasts, and peer-reviewed journal articles. Whether you’re a seasoned professional or new to the field, our resources are here to support your understanding of the latest information.
Join us in celebrating the achievements and innovations that are transforming patient care across multiple specialties. Connect with us to stay informed and inspired by the ever-evolving landscape of biosimilars.
ESMO Annual Meeting 2024
- ESMO 2024 Highlights in Breast and Colorectal Cancers
- Colorectal Cancer Video Interview
- Breast Cancer Video Interview
Please note: Video Interviews will be published as they become available.
Breast, Colorectal, and Hepatocellular Cancer Highlights – ESMO Congress 2024
The European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain on September 13–17, 2024 and included 269 sessions and 2186 abstracts. Its comprehensive program included sessions that could potentially change clinical practice, that highlighted advances in translational cancer science, and fostered multidisciplinary discussions.
Authored by Zoya Marinova, MD, PhD (Illinois, USA). Reviewed by Jawaher Ali Khan Ansari, MD (Abu Dhabi, United Arab Emirates), Ahmad Awada, MD, PhD (Brussels , Belgium) and Debora Gagliato, MD (São Paulo, Brazil)
ESMO 2024 Video Interviews
Colorectal Cancer Research Highlights from ESMO 2024
An Interview with Prof. Dirk Arnold
Prof. Dirk Arnold spoke with Karger following the conference to reflect on the presentations and practice-changing information given at the conference for CRC patients and healthcare professionals.
EADV Annual Meeting 2024
- EADV 2024 Highlights in Plaque Psoriasis and Hidradenitis Suppurativa
- Hidradenitis Suppurativa Video Interview
- Plaque Psoriasis Video Interview
Plaque Psoriasis and Hidradenitis Suppurativa Highlights – EADV Conference 2024
The EADV Congress 2024 which was held in Amsterdam, the Netherlands, between the 25th and 28th of September 2024, covered an exciting range of topics in dermatology and venereology and attracted healthcare professionals and industry specialists. The topic of plaque psoriasis was featured in six sessions spanning 56 presentations and 346 ePosters, while hidradenitis suppurativa was covered in three sessions with 31 presentations and 108 ePosters.
Authored by Guy Regnard PhD (Cape Town, South Africa). Reviewed by Falk Bechara MD, PhD (Department of Dermatology, Venereology and Allergology, International Centre for Hidradenitis Suppurativa/Acne Inversa (ICH), Ruhr-University Bochum, Bochum, Germany) and Benhadou Farida MD, PhD (Hôpitaux Universitaires de Bruxelles, Brussels, Belgium)
EADV 2024 Video Interviews
Dr. Thrasyvoulos Tzellos of Nordland Hospital Trust, Norway, spoke with us following the conference on the topics of Hidradenitis Suppurativa and Plaque Psoriasis.
New Clinical Guidance for Hidradenitis Suppurativa: Highlights from EADV 2024
Hidradenitis suppurativa was covered across 31 presentations and 108 ePosters at this years EADV Congress, including the discussion of new clinical guidelines for disease management.
What is Missing in Plaque Psoriasis Management? Highlights from EADV 2024
The 2024 EADV congress, held 25-28th September 2024, covered a range of topics in dermatology and venereology. Across 56 presentations in 6 sessions, and 346 ePosters, the latest on plaque psoriasis treatment and management was discussed among thousands of attendees.
AAO Annual Meeting 2024
- AAO 2024 Conference Summary
- Video Interviews
Age-related Macular Degeneration and Diabetic Macular Edema Highlights – American Academy of Ophthalmology 2024
The American Academy of Ophthalmology (AAO) annual meeting was held in Chicago on 18–21 October and included subspecialty days on 18–19 October. Retina 2024 had twenty sections featuring a wide range of retinal diseases and treatments, including age-related macular degeneration (AMD) and diabetic macular edema (DME).
Authored by Guy Regnard, PhD (Cape Town, South Africa). Reviewed by Rohan Chauhan, MBBS (Ahmedabad, India)
SABCS Annual Meeting 2024
- SABCS 2024 Conference Summary
- Video Interviews
Please note: Content will be available end of December 2024
EULAR Annual Meeting 2025
- EULAR 2025 Conference Summary
- Video Interviews
Please note: Content will be available after June 2025
ADA Annual Meeting 2025
- ADA 2025 Conference Summary
- Video Interviews
Please note: Content will be available after June 2025
ASCO Annual Meeting 2022
The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) was held in Chicago, IL on June 3–7, 2022 with both in-person and online attendance.
The theme of the meeting was “Advancing Equitable Cancer Care Through Innovation”, and it included over 200 sessions revealing novel findings in cancer research, therapy, and care. Advances in breast cancer research and therapeutics were the conference topics attracting broadest interest.
The following publications provide an overview of topics discussed at the ASCO Annual Meeting 2022 and highlight some of the key messages and takeaways.
Breast Cancer Highlights
This sheet summarizes all the key findings from the 2022 Annual ASCO meeting. A healthcare resource developed by Karger. Decisions regarding the content of the resource rests with the named authors and contributors.
Authored by Dr Zoya Marinova (United States), with contributions from Dr Vinícius Knackfuss Gonçalves (Brazil) and Prof. Bernardo L Rapoport (South Africa).
Expert Discussion Breast Cancer
In this article, the latest advancements presented at the 2022 Annual ASCO Meeting regarding metastatic breast are reviewed. The independent manuscript submitted by the authors has undergone single-blind peer-review.
Authored by Marija Balic, Kerstin Wimmer, Christoph Suppan, Tajana Silovski, and Christine Brunner.
Conference Commentary Breast Cancer
This article reflects expert discussion on PALOMA-2 OS data presented at the 2022 Annual ASCO Meeting.
The independent manuscript submitted by the authors has undergone single-blind peer-review.
Authored by Shaheenah Dawood; A.F.M. Kamal Uddin; Sewanti Limaye.
Breast Cancer - Fast Facts Oncology Podcast
Fast Facts Oncology is a five-part special that focuses on breast cancer, specifically looking at issues pertinent to low- and middle-income countries (LMICs). We are joined experts Dr Vinicius Goncalves, Dr Shaheenah Dawood, Dr Omar Hamid and Adeda Steenkamp from the Cancer Association of South Africa.
Listen the series Podcast Fast Facts Oncology - S1 - Karger Publishers and on all major streaming platforms.
Breast Cancer - An Interview with Abeda Steenkamp
For Breast Cancer Awareness Month in October we turned to the Cancer Association of South Africa (CANSA) to learn more about their mission and vision.
We spoke with Abeda Steenkamp about stigma and taboos surrounding cancer that she sees in South Africa. Furthermore, she shares her own experiences as a breast cancer patient, discusses the important role of education and support, and gives an insight into her work and tasks as a Service Coordinator for CANSA.
ESMO Annual Meeting 2022 – Breast Cancer and Colorectal Cancer
- Colorectal Cancer Highlights
- Colorectal Cancer Supplement Issue
- Breast Cancer Video Interviews
- Colorectal Cancer Interview
Colorectal Cancer Highlights
This sheet summarizes all the key findings from the 2022 ESMO annual meeting.
A healthcare resource developed by Karger. Decisions regarding the content of the resource rests with the named authors and contributors:
Authored by Dr. Guy Regnard (South Africa). Reviewed by Prof. Dr. Dirk Arnold (Germany), Dr. Rosario Pitargue (Philippines), Dr. Maria Belen E. Tamayo (Philippines).
Colorectal Cancer Supplement Issue
This supplement issue to the journal Oncology aims to describe the current treatment approaches for metastatic colorectal cancer and their implications for low- and middle-income countries. It is an independent publication for which the articles have been submitted by the authors and have undergone single-blind peer-review.
-
Current Treatment Approaches for Metastatic Colorectal Cancer and their Implications for Low and Middle Income Countries
Maheboob Basade
Oncology 2023 Vol. 101, Suppl. 1 (DOI:10.1159/000530415) -
Preface
Maheboob Basade
Oncology (2023) 101 (Suppl. 1): 1. (DOI:10.1159/000530415) -
The Cancer Treatment Gap in Lower- to Middle-Income Countries
Claudia Cardone; Dirk Arnold
Oncology (2023) 101 (Suppl. 1): 2–4. (DOI:10.1159/000530416) -
Practical Notes on the Current ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer in Resource-Constrained Environments of Low- to Middle-Income Countries
Jean-Marc Maurel; Maria Belen Tamayo; Rosario Pitargue; Annielyn Beryl Ong-Cornel; Piyush Mehta; Doudou Diouf; Chetan Deshmukh; Maheboob Basade; Salif Balde; Eunice Adanza-Cutillar; Shaheenah Dawood
Oncology (2023) 101 (Suppl. 1): 5–8. (DOI:10.1159/000530275)
Breast Cancer Video Interviews
Exploring the Latest Trial Data & Advances in Breast Cancer Treatments
An Interview with Dr. Hope Rugo
Welcome to the third episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer we speak with Dr Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr Rugo summarizes the TROPICS02 trial that she presented at this year's conference. We also discuss how data presented from the METEORA and ICON trials add to clinical understandings of immunotherapy response. Coverage is also provided to the ADAPT trial. Finally, we discuss how these clinical improvements in response and progression free survival (PFS) translate to the patient experience.
Clinical Trial Updates in Breast Cancer Management
An Interview with Dr. Shaheenah Dawood
Welcome to the second episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer, we speak with Dr Shaheenah Dawood, a practicing medical oncologist from Dubai, United Arab Emirates. Dr Dawood discusses the MONARCH3 trial – its background, recent findings and how it differs from the MONARCHER trial. Coverage is also given to the presentations on oral selective estrogen receptor downregulators (SERDs) as a treatment option for breast cancer patients.
The Latest Updates in Colorectal Cancer
An Interview with Dr. Chetan Deshmukh
Welcome to the first episode in a three-part special live from ESMO 2022. In this episode focused on colorectal cancer, we speak with Dr Chetan Deshmukh, a practicing medical oncologist from Pune, India. Dr Deshmukh discusses the results from the CARIO5 study which have been presented at the congress. He also shares with us his thoughts on the promise of novel immunotherapeutics and targeted therapies in CRC management and provides his perspective on disparities in drug access in low-middle income countries.
